MARKET

IBB

IBB

iShares Biotechnology ETF
NASDAQ
148.26
+1.23
+0.84%
After Hours: 149.10 +0.84 +0.57% 19:54 07/26 EDT
OPEN
147.51
PREV CLOSE
147.03
HIGH
149.45
LOW
147.37
VOLUME
902.06K
TURNOVER
0
52 WEEK HIGH
149.45
52 WEEK LOW
111.62
TOTAL ASSET
7.82B
YTD YIELD
14.33%
1D
5D
1M
3M
1Y
5Y
1D
Sector Update: Health Care Stocks Mixed Premarket Thursday
NASDAQ · 1d ago
Weekly Report: what happened at IBB last week (0715-0719)?
Weekly Report · 4d ago
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
NASDAQ · 07/19 13:04
Gilead Sciences' Q2 2024 Earnings: What to Expect
Gilead Sciences, Inc. Is set to announce its fiscal Q2 earnings results after the market closes on Thursday, Aug. 8. The company is expected to report a profit of $1.58 per share. GILD stock has declined 9.5% on a YTD basis. The consensus opinion on the company's stock is optimistic.
Barchart · 07/18 14:23
HQH: Discount Remains Attractive With A Now Higher Distribution Rate
Abrdn Healthcare Investors Fund focuses on the more cyclical biotech space, with over half of its portfolio allocated there. The fund's managed distribution policy was increased significantly since our prior update. The abrdn healthcare investors fund continues to trade at an attractive discount. Discount Narrows With Distribution Increase But Remains Appealing.
Seeking Alpha · 07/17 20:33
ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors
Seeking Alpha · 07/17 08:42
Sector Update: Health Care Stocks Rise Pre-Bell Tuesday
NASDAQ · 07/16 13:18
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
NASDAQ · 07/16 10:20
More
Profile
Fund Name
iShares Biotechnology ETF
Inception Date
2001-02-05
Benchmark
ICE Biotechnology TR USD
Advisor Company
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank NA
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead